Mouse models for studying pain in sickle disease: Effects of strain, age, and acuteness

British Journal of Haematology

Volumn 156, Issue 4, 2012, Pages 535-544

  Cain, David M ^a,b   Vang, Derek ^a   Simone, Donald A ^b   Hebbel, Robert P ^a   Gupta, Kalpna ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Hypoxia; Ischaemia; Pain; Reperfusion injury; Sickle cell disease

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLD TREATMENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEAT SENSITIVITY; HEAT TREATMENT; HYPERALGESIA; HYPOXIA; MALE; MECHANICAL STIMULATION; MOUSE; MOUSE STRAIN; MUSCULOSKELETAL PAIN; NOCICEPTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REOXYGENATION; SICKLE CELL ANEMIA; TRANSGENE;

AGE FACTORS; ANALGESICS; ANEMIA, SICKLE CELL; ANIMALS; ANOXIA; CYCLOHEXANOLS; DISEASE MODELS, ANIMAL; HUMANS; HYPERALGESIA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PAIN; PAIN MEASUREMENT; RECEPTORS, CANNABINOID; TEMPERATURE;

EID: 84856255925     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08977.x     Document Type: Article

References (33)

1. Ballas, S.K. (2007) Current issues in sickle cell pain and its management. Hematology/the Education Program of the American Society of Hematology, 97-105.
2. Belcher, J.D., Bryant, C.J., Nguyen, J., Bowlin, P.R., Kielbik, M.C., Bischof, J.C., Hebbel, R.P. & Vercellotti, G.M. (2003) Transgenic sickle mice have vascular inflammation. Blood, 101, 3953-3959.
3. Carden, D.L. & Granger, D.N. (2000) Pathophysiology of ischaemia-reperfusion injury. The Journal of Pathology, 190, 255-266.
4. Chaplan, S.R., Pogrel, J.W. & Yaksh, T.L. (1994) Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. Journal of Pharmacology and Experimental Therapeutics, 269, 1117-1123.
5. Dampier, C.D., Setty, B.N., Logan, J., Ioli, J.G. & Dean, R. (1995) Intravenous morphine pharmacokinetics in pediatric patients with sickle cell disease. Journal of Pediatrics, 126, 461-467.
6. Dampier, C., Ely, B., Brodecki, D. & O'Neal, P. (2002) Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports. The Journal of Pain, 3, 461-470.
7. Darbari, D.S., Neely, M., van den Anker, J. & Rana, S. (2011) Increased clearance of morphine in sickle cell disease: implications for pain management. The Journal of Pain, 12, 531-538.
8. Elikkottil, J., Gupta, P. & Gupta, K. (2009) The analgesic potential of cannabinoids. Journal of Opioid Management, 5, 341-357.
9. Fabry, M.E., Nagel, R.L., Pachnis, A., Suzuka, S.M. & Costantini, F. (1992) High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. Proceedings of the National Academy of Sciences of the United States of America, 89, 12150-12154.
10. Fabry, M.E., Sengupta, A., Suzuka, S.M., Costantini, F., Rubin, E.M., Hofrichter, J., Christoph, G., Manci, E., Culberson, D., Factor, S.M. & Nagel, R.L. (1995) A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbSS-Antilles results in increased phenotypic severity. Blood, 86, 2419-2428.
11. Fuchs, D., Birklein, F., Reeh, P.W. & Sauer, S.K. (2010) Sensitized peripheral nociception in experimental diabetes of the rat. Pain, 151, 496-505.
12. Ganguly, A., Boswell, W. & Aniq, H. (2011) Musculoskeletal manifestations of sickle cell anaemia: a pictorial review. Anemia, 2011, 794283.
13. Hamamoto, D.T., Giridharagopalan, S. & Simone, D.A. (2007) Acute and chronic administration of the cannabinoid receptor agonist CP 55, 940 attenuates tumor-evoked hyperalgesia. European Journal of Pharmacology, 558, 73-87.
14. Hargreaves, K., Dubner, R., Brown, F., Flores, C. & Joris, J. (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 32, 77-88.
15. Hidalgo, A., Chang, J., Jang, J.-E., Peired, A.J., Chiang, E.-Y. & Frenette, P.S. (2009) Heterotypic interactions enabled by polarized neutrophil microdomains mediate thrombo-inflammatory injury. Nature Medicine, 15, 384-391.
16. Hillery, C.A., Kerstein, P.C., Vilceanu, D., Barabas, M.E., Retherford, D., Brandow, A.M., Wandersee, N.J. & Stucky, C.L. (2011) Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease. Blood, 118, 3376-3383.
17. Honore, P., Rogers, S.D., Schwei, M.J., Salak-Johnson, J.L., Luger, N.M., Sabino, M.C., Clohisy, D.R. & Mantyh, P.W. (2000) Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience, 98, 585-598.
18. Kalambur, V.S., Mahaseth, H., Bischof, J.C., Kielbik, M.C., Welch, T.E., Vilback, A., Swanlund, D.J., Hebbel, R.P., Belcher, J.D. & Vercellotti, G.M. (2004) Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy. American Journal of Hematology, 77, 117-125.
19. Kaul, D.K. & Hebbel, R.P. (2000) Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. Journal of Clinical Investigation, 106, 411-420.
20. Kaul, D.K., Liu, X.D., Choong, S., Belcher, J.D., Vercellotti, G.M. & Hebbel, R.P. (2004) Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. American Journal of Physiology. Heart and Circulatory Physiology, 287, H293-H301.
21. Khasabova, I.A., Khasabov, S.G., Harding-Rose, C., Coicou, L.G., Seybold, B.A., Lindberg, A.E., Steevens, C.D., Simone, D.A. & Seybold, V.S. (2008) A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain. Journal of Neuroscience, 28, 11141-11152.
22. Kohli, D.R., Li, Y., Khasabov, S.G., Gupta, P., Kehl, L.J., Ericson, M.E., Nguyen, J., Gupta, V., Hebbel, R.P., Simone, D.A. & Gupta, K. (2010) Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. Blood, 116, 456-465.
23. Kollander, R., Solovey, A., Milbauer, L.C., Abdulla, F., Kelm, Jr, R.J. & Hebbel, R.P. (2010) Nuclear factor-kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease. Translational Research, 155, 170-177.
24. Li, Y., Hsieh, S.T., Chien, H.F., Zhang, X., McArthur, J.C. & Griffin, J.W. (1997) Sensory and motor denervation influence epidermal thickness in rat foot glabrous skin. Experimental Neurology, 147, 452-462.
25. Lunzer, M.M., Yekkirala, A., Hebbel, R.P. & Portoghese, P.S. (2007) Naloxone acts as a potent analgesic in transgenic mouse models of sickle cell anemia. Proceedings of the National Academy of Sciences of the United States of America, 104, 6061-6065.
26. Mogil, J.S., Wilson, S.G., Bon, K., Lee, S.E., Chung, K., Raber, P., Pieper, J.O., Hain, H.S., Belknap, J.K., Hubert, L., Elmer, G.I., Chung, J.M. & Devor, M. (1999) Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain, 80, 67-82.
27. National Heart, Lung, and Blood Institute Division of Blood Diseases and Resources (2002) The Management of Sickle Cell Disease, NIH Publication Number 02-2117. National Institutes of Health, Bethesda, MD.
28. Osarogiagbon, U.R., Choong, S., Belcher, J.D., Vercellotti, G.M., Paller, M.S. & Hebbel, R.P. (2000) Reperfusion injury pathophysiology in sickle transgenic mice. Blood, 96, 314-320.
29. Paszty, C., Brion, C.M., Manci, E., Witkowska, H.E., Stevens, M.E., Mohandas, N. & Rubin, E.M. (1997) Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science, 278, 876-878.
30. Ristoiu, V., Shibasaki, K., Uchida, K., Zhou, Y., Ton, B.H., Flonta, M.L. & Tominaga, M. (2011) Hypoxia-induced sensitization of transient receptor potential vanilloid 1 involves activation of hypoxia-inducible factor-1 alpha and PKC. Pain, 152, 936-945.
31. Smith, W.R. (2011) Pain in sickle cell disease: the future of acute treatment. Expert Review of Hematology, 4, 237-239.
32. Solovey, A., Kollander, R., Shet, A., Milbauer, L.C., Choong, S., Panoskaltsis-Mortari, A., Blazar, B.R., Kelm, Jr, R.J. & Hebbel, R.P. (2004) Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin. Blood, 104, 840-846.
33. Tuma, R.F. & Steffens, S. (2011) Targeting the endocannabinoid system to limit myocardial and cerebral ischemic and reperfusion injury. Current Pharmaceutical Biotechnology. Epub ahead of print) PMID: 21470162.